SightfileU.S. market data from official filings

SOLVENTUM CORP (SOLV)

Name: SOLVENTUM CORP (SOLV) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001964738 · EDGAR filings · Updated 2026-07-20

SOLVENTUM CORP (SOLV) has reported institutional ownership of 74.3%, with 873 institutional managers holding positions valued at $8.40B per the latest 13F reporting period.

Institutional ownership

74.3%

Institutional managers

873

Reported 13F value

$8.40B

Insider activity

66 trans.

−$646.3M net selling

Latest updates

2026-07-20 — Current report (8-K) filed
2026-06-05 — Current report (8-K) filed
2026-05-29 — SD filed
2026-05-27 — Current report (8-K) filed
2026-05-20 — Current report (8-K) filed
2026-05-18 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SOLVENTUM CORP has 873 institutional holders and institutional ownership of 74.3%.

Insider activity

Insiders reported 66 transactions (1 buys, 1 sells) across 20 reporting insiders, with a net reported value of −$646.3M.

Related companies

BRIGHTSPRING HEALTH SVCS INC (BTSG) · BAXTER INTL INC (BAX) · ICON PLC (ICLR) · PROTAGONIST THERAPEUTICS (PTGX) · KYMERA THERAPEUTICS (KYMR) · HALOZYME THERAPEUTICS INC (HALO)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-20.